By Notice dated September 16, 2004, and published in the Federal Register on September 30, 2004, (69 FR 58539-58540), Cambridge Isotope Laboratory, 50 Frontage Road, Andover, Massachusetts 01810, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II:
The company plans to manufacture small quantities of the listed controlled substances to produce isotope labeled standards for drug analysis.
No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cambridge Isotope Laboratory to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cambridge Isotope Laboratory to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.Start Signature
Dated: February 22, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 05-4204 Filed 3-3-05; 8:45 am]
BILLING CODE 4410-09-P